Tenafin 0.01 is a Product of the Generic Butenafine Hydrochloride

Tenafin 0.01 belongs to the generic category of Butenafine Hydrochloride. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Tenafin 0.01. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Butenafine Hydrochloride and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Tenafin 0.01

Tenafin 0.01 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Tenafin 0.01 is provided below to help users gain a clear understanding of this medicine.

What Is Tenafin 0.01 Indications and Uses?

Butenafine cream is indicated for the topical treatment of the following superficial dermatophytosis: Interdigital tinea pedis (athlete's foot); Tinea corporis (ringworm); Tinea cruris (jock itch) due to E. floccosum, T. mentagrophytes, T. rubrum, and T. tonsurans.

Pharmacology (Source, Chemical and Physical Composition) Of Tenafin 0.01

Butenafine is a synthetic antifungal agent that is structurally and pharmacologically related to allylamine antifungals. The exact mechanism of action has not been established, but it is suggested that butenafine's antifungal activity is exerted through the alteration of cellular membranes, which results in increased membrane permeability, and growth inhibition. Butenafine is mainly active against dermatophytes and has superior fungicidal activity against this group of fungi when compared to that of terbinafine, naftifine, tolnaftate, clotrimazole, and bifonazole. It is also active against Candida albicans and this activity is superior to that of terbinafine and naftifine. Butenafine also generates low MICs for Cryptococcus neoformans and Aspergillus spp. as well.

Dosage And Administration of Tenafin 0.01

In the treatment of interdigital tinea pedis, Butenafine should be applied twice daily for 7 days or once daily for 4 weeks. Patients with tinea corporis or tinea cruris should apply Butenafine once daily for two weeks. Sufficient Butenafine cream should be applied to cover affected areas and immediately surrounding skin of patients with interdigital tinea pedis, tinea corporis and tinea cruris.

Drug Interactions of Tenafin 0.01

Potential drug interactions between butenafine HCl cream and other drugs have not been evaluated.

Side Effects of Tenafin 0.01

Rarely local mild burning or irritation may be experienced. Hypersensitivity reactions may occur.

Use During Pregnancy and Lactation

Pregnancy Category C. As no adequate and well-controlled studies have been conducted, this drug should be used during pregnancy only if clearly needed. It is not known if butenafine HCl is excreted in human milk. Caution should be exercised in prescribing butenafine HCl to a nursing woman.

Precautions And Warnings for Tenafin 0.01

Butenafine cream is not for ophthalmic, oral, or intravaginal use. This is for external use only. If irritation or sensitivity develops with the use of Butenafine cream, treatment should be discontinued and appropriate therapy instituted.

Use In Special Populations

Safety and efficacy in pediatric patients below the age of 12 years have not been studied.

Therapeutic Class

Topical Antifungal preparations

Storage Conditions of It

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.